National Lung Cancer Partnership/LUNGevity Foundation Research Grants
National Lung Cancer Partnership/LUNGevity Foundation
All Regions
09/02/2008
$100,000

National Lung Cancer Partnership/The LUNGevity Foundation
2008 Research Grant Program
Request for Applications

Purpose of Grant
The purpose of this Grant Program is to drive research forward that will increase understanding of lung cancer risk, biology, and response to treatment. National Lung Cancer Partnership and the LUNGevity Foundation are particularly interested in research that will aid in prevention, detection, diagnosis, screening, treatment, and symptom management of lung cancer. Two grants are available:
• One Grant is available specifically for research in the area of sex differences in lung cancer.
• One Grant is available for research pertaining to any facet of lung cancer.

The Research Grant is intended as seed money for promising novel research for a faculty member at any level to carry out research in lung cancer. The Research Grant will be awarded for one or two years, for up to $50,000 per year ($100,000 maximum over 2 years). The Grant is designed to be used primarily for research support, including technical assistance, supplies, reagents, and equipment. It is the policy of National Lung Cancer Partnership and the LUNGevity Foundation not to provide indirect costs to the Grant recipient’s institution.

Eligibility
1. At the time of application, an applicant must hold a doctoral degree (MD, PhD, DO, DrPH, or equivalent), have completed all post-doctoral training, and have a faculty appointment at any not-for-profit institution anywhere in the world. Pre- and post-doctoral fellows and research associates are not eligible for the Research Grant.
2. Applications will only be accepted for Research Plans involving lung cancer research. Applications addressing sex differences in lung cancer are especially encouraged.
3. The Research Plan may be carried out at any accredited non-profit research institution throughout the world. If the applicant is performing research outside of their home country, verification of work visa must be provided.
4. The Research Grant recipient may hold any other fellowship, award, or grant during the time of the award.
5. The Research Grant recipient may not have knowingly received any research funding from the tobacco industry, its parent companies or subsidiaries, within the last 5 years.
6. Applications involving animals must receive approval from the institution’s Animal Care and Use Committee before award commencement.
7. Applications involving human participants must receive approval from the local Institutional Review Board before award commencement.
8. National Lung Cancer Partnership and the LUNGevity Foundation will not discriminate on the basis of gender, race, creed, religion, sexual orientation, disability, nationality, age or any other factor irrelevant to the quality of the application.

Award Information
The deadline for grant applications is September 2, 2008. Applications must be electronically submitted and postmarked on or before this deadline. Awards will be announced on or before December 15, 2008.

The Research Grant is subject to annual review, and may be granted for a maximum of $50,000 per year for two years. The second year of support is based on the applicant’s demonstration of satisfactory progress.

Contact Us

National Lung Cancer Partnership
222 N. Midvale Blvd., Suite 6
Madison, WI 53705

Phone: 608.233.7905
Fax: 608.233.7893

E-mail: info@NationalLungCancerPartnership.org
www.NationalLungCancerPartnership.org

Distinguished Investigator, Distinguished Scholar, Distinguished Scientist, Established Investigator, Junior Faculty, Medical School Faculty, Oncologist, Scientist, Senior Investigator, Senior Researcher, Physician Researcher
Clinical Research Grant Awards--Pediatric Physical Therapy.
Section on Pediatrics American Physical Therapy Association
All Regions
09/01/2008
$30,000
Clinical Research Grant Awards

Purpose & Deadlines

Four $5,000 awards, two $10,000 awards, and one $30,000 are available to Section to Pediatrics members to assist with a 1-year research study that investigates a question or questions of importance to pediatric physical therapy. The purposes of the grants are to provide funding to assist primarily new physical therapist investigators and to encourage research that will add to the body of knowledge related to improvement of pediatric physical therapy. The $30,000 is earmarked for a planning grant for a multi-site study in early intervention. A request for applications (RFA) and details about this award will be published.

The due date for submissions is April 1 and September 1 . The grants can be given to support post-professional thesis or dissertation research. (Monies not awarded after the April submission reviews may be awarded to October submissions.) Calls for submissions are routinely advertised in the Section on Pediatrics Newsletter and in Pediatric Physical Therapy, the Section journal. Proposals must be e-mailed by the due date (or by the following Monday, if the due date falls on a weekend) to be eligible for review. To apply, send two electronic copies of your proposal, one with identifying information (author names, place of research, etc) and one with all identifying information deleted (do not just change the font color) to the Section on Pediatrics’ Executive Office at pediatrics@apta.org.
Physical Therapist, Allied Health Professional
Career Development Award in Liver Transplantation
American Association for the Study of Liver Diseases
All Regions
09/02/2008
$90,000

2009 AASLD
CAREER DEVELOPMENT AWARD
IN LIVER TRANSPLANTATION IN MEMORY OF THE
UNIVERSITY OF MICHIGAN TRANSPLANT TEAM
Application Deadline: September 2, 2008
DESCRIPTION
The purpose of this award is to foster career development for an individual performing clinical and/or
translational research in the field of liver transplantation and who has shown commitment to
excellence in the field at an early stage of his or her career.
OBJECTIVE
The award is designed to support a junior faculty member in the development of liver transplant
research so that further funding can be obtained.
ELIGIBILITY
In order to be eligible for this award, the applicant must meet the following criteria:
1. Applicant must be in the first five years of appointment as a junior faculty member (instructor
or assistant professor) at a UNOS approved transplant center who spends 50% or more of
his/her time in clinical transplantation or transplantation-related sciences.
2. Applicant must show commitment to making substantial contributions to the field of liver
transplantation.
3. Applicant does not hold other similar research awards. Applicants who hold other research
awards (NIH-K08, NIH-K23, Veterans Administration-Research Associate, Clinical
Investigator, AGA Research Scholar Award, Glaxo Institute of Digestive Health Award,
American Liver Foundation Liver Scholar Award, etc.) are not eligible.
4. Sponsor should be the applicant's research mentor and must be an AASLD member in good
standing.
5. Applicant must be an AASLD member in good standing by the award start date.
AWARD AND REQUIREMENTS
One award of $90,000 will be provided over two years ($45,000 per year). Money may be used for
salary support or for technical support/laboratory supplies for the investigator and no indirect costs
are provided. It is expected that additional funds are available to the candidate in order to carry out
the proposed research.
This award is intended to support the recipient’s continued research. Funds will be issued to the
recipient’s institution and are not transferable from one recipient to another. The award cannot be
transferred to another institution without prior written approval from AASLD.
Recipients must acknowledge the award in all publications resulting from research performed during
the tenure of this award. Abstracts, manuscripts, or other articles that reflect research funded by
this award must acknowledge support from AASLD, and copies must be forwarded to AASLD. In
addition, a scientific progress and financial report must be sent to AASLD at the end of each award
year and at the time when the award is complete. Funding of the second year of the award is
contingent upon receipt of a first year progress report. All awardees are strongly encouraged to
present their work at The Liver Meeting®.
SELECTION CRITERIA
Candidates will be evaluated based upon their background, their commitment to a research career,
the strength of their research project and the environment in which they will conduct this project.
REVIEW PROCESS
The AASLD Awards Committee will review the nominations received by the submission deadline and
will make final recommendations to the AASLD Governing Board.
DEADLINE
Send the original and 14 three-hole punched copies of the completed application (including support
materials) in one package by 5 pm Eastern on September 2, 2008 to AASLD, 1001 N. Fairfax St.,
Suite 400, Alexandria, VA 22314 Attention: Career Development Award
Note: Do not staple any part of the application package.
NOTIFICATION DATE/START DATE
Notification date will be October 2008 for a July 2009 start date. Recipients will be recognized
during The Liver Meeting® 2008, October 31 - November 4 in San Francisco, California.
Support of this award by Astellas USA Foundation is gratefully acknowledged.

Questions? Contact Denise Davis or Kristin Hutcherson via email at awards@aasld.org or call 703-299-9766.

Hepatologist, Junior Faculty, Junior Investigator, Junior Researcher, Junior Scientist, Young Investigator, Young Scientist, Physician Researcher
2009 AASLD Advanced/Transplant Hepatology Fellowship Program
American Association for the Study of Liver Diseases
All Regions
09/02/2008
$60,000
2009 AASLD
ADVANCED/TRANSPLANT HEPATOLOGY
FELLOWSHIP PROGRAM
APPLICATION DEADLINE:
September 2, 2008
DESCRIPTION
The purpose of this program is to provide salary and benefit support for GI fellows pursuing an additional,
full-year of training focused on patient care in advanced/transplant hepatology, beginning on July 1, 2009.
The intent of the training program is to prepare the trainee to be eligible for certification in transplant
hepatology by the American Board of Internal Medicine (ABIM).
ELIGIBILITY
In order to be eligible for this award, the applicant must meet the following criteria:
1. The applicant must complete his/her GI fellowship training (at an ACGME approved
institution) in the U.S. by July 1, 2009 or have been accepted to a U.S. GI training
program (ACGME approved) beginning between July 1, 2010 and July 1, 2011.
2. The sponsoring institution must have a United Network for Organ Sharing (UNOS)
approved liver transplant program, which must be in good standing and must perform at
least 10 liver transplantations per year. The program must have a full-time faculty
member or members capable of teaching a curriculum with a broad-base of knowledge
in transplant medicine and hepatology. The program must provide training in living
donor transplantation.
3. The applicant must have a faculty mentor who is active in hepatology at the applicant’s
sponsoring institution.
4. The applicant must be member of AASLD.
5. The applicant will be mentored during the fellowship period (July 1, 2009 – June 30,
2010) by a member of AASLD.
6. The applicant is a citizen or permanent resident of the U.S. or recipient of a student or
trainee Visa to the U.S.
7. The award is strictly for an additional year of clinical hepatology fellowship training and
the applicant may not be faculty during the fellowship period (July 1, 2009 – June 30,
2010).
8. The applicant will not hold other, similar fellowship awards during the fellowship period
(July 1, 2009 – June 30, 2010).
AWARDS AND REQUIREMENTS
An award of $60,000 will be provided for one year. Money is for salary and benefit support (up to 8% or
$4,800) only for the fellow. Awards are granted to the individual applicant, not the applicant’s institution.
However, funds will be paid directly to the awardee’s institution. In addition, the fellow’s travel-related
expenses incurred to attend the 2009 AASLD Annual Meeting and 2010 Digestive Disease Week® will be
reimbursed up to $2,000 per meeting and according to guidelines provided prior to each meeting.
Awards cannot be transferred to another institution and recipients cannot change their mentor without
prior written approval from AASLD.
Rev 4/09/2008
Recipients must provide a final report by October 1, 2010, summarizing their activities related to this
award. The report is to be sent to AASLD and is not considered confidential. In addition, a financial
report from the institution must be sent to AASLD at the end of the award year, together with any
unexpended funds, also no later than October 1, 2010. The awardee’s institution will be notified of reports
that are not received in a timely manner.
In the event that a grant is canceled, AASLD can not assume responsibility for expenditures in excess of
payments already made to the awardee’s institution prior to the effective date of cancellation. All
unexpended funds must be returned to AASLD. If an award is to be canceled, the recipient must provide
written explanation to AASLD.
SELECTION CRITERIA
Candidates will be evaluated based upon their background and their commitment to a career in adult or
pediatric clinical hepatology. Specifically, candidates will be reviewed based on:
• Professional potential of the applicant
• Experience, productivity, and commitment of the faculty mentor(s)
• Clinical and/or academic environment
• Quality of proposed clinical program
AASLD will review the applications and select recipients of the award. Applications will be reviewed based
only on the written materials submitted. All decisions are final. Incomplete applications and
applications that fail to adhere strictly to the instructions (including the submission deadline
and page limitations) will not be reviewed. Selection decisions will be announced by January 2009.
SUBMISSION PROCESS AND DEADLINE
An unbound original and 14 copies of the completed application (including support materials) must be
received by September 2, 2008 at 5:00 pm Eastern and should be sent in a single package addressed
to:
American Association for the Study of Liver Diseases
ATTN: Advanced/Transplant Hepatology Fellowship Program
1001 North Fairfax Street, Suite 400
Alexandria, VA 22314
Note: Only official application forms and copies thereof will be accepted. Applications and application
components faxed or received after the deadline will not be accepted for consideration.
NOTIFICATION DATE/START DATE
Notification date will be January 2009 for a July 2009 start date.
Questions and requests for additional applications should be addressed to AASLD, phone 703/299-9766,
fax 703/299-9622, email awards@aasld.org.
Hepatologist
Bridging Grant
American Association for the Study of Liver Diseases
All Regions
09/02/2008
$75,000
2008
AASLD BRIDGING GRANT
$75,000 ONE YEAR AWARD
Deadline: September 2, 2008
DESCRIPTION
The purpose of this award is to assist an investigator who was not awarded his/her first R01 or the
renewal of his/her R01 to continue hepatology-related research.
OBJECTIVE
To provide interim support to AASLD members who have submitted grants to NIH or the United
States Department of Veteran’s Affairs, which were approved on the basis of scientific merit, but
received priority scores out of the funding range.
ELIGIBILITY
In order to be eligible for this award, the applicant must meet the following criteria:
1. Applicant must be a Regular member in good standing of AASLD.
2. Applicant must have a dedicated interest in liver disease and be applying for his/her first R01
(this includes investigators transitioning from a K award to their first R01) or his/her second
R01, either as a competitive renewal or a new R01. Established investigators holding other
types of grants (i.e. AASLD Research Awards, ALF Liver Scholar, etc) but who are applying for
their first R01 may also apply.
3. Applicant must hold an MD, PhD, or equivalent degree (e.g., MB, ChB, MBBS, DO).
4. Applicant must hold a full-time faculty position at a North American university or professional
institute at the time of application.
5. Applicant must have submitted a proposal to NIH or Veteran’s Administration that has
undergone the peer review process and was either approved and not funded or received high
commendation but not funded. Streamlined applications do not qualify for the Bridging Grant.
Applications must have received a 20th or lower percentile on the NIH scale (this will be
adjusted as the payline changes).
6. Applicant may apply to other agencies for bridging funds (AGA, ACG, etc) but cannot receive
more than $75,000 of additional extramural research support during the AASLD Bridging
Grant-funded period. AASLD funds must be returned immediately upon receipt of any funds
over the additional $75,000 limit.
AWARDS AND REQUIREMENTS
One award of $75,000 will be provided over one year. Money may be used for salary support or for
technical support/laboratory supplies for the investigator; indirect costs are not allowed nor are
funds meant to support travel. It is expected that additional funds are available to the candidate in
order to carry out the proposed research. The recipient cannot receive more than $75,000 of
additional extramural research support during the time of the AASLD Bridging Grant-funded period.
Awards cannot be transferred to another institution without prior written approval from AASLD.
The recipient of this award must notify AASLD if the revised R01 or VA Merit Review Grant
application is awarded. All unexpended funds must be returned to AASLD at the time R01 or Merit
Award funding begins. Upon completion of the funded period, a scientific progress and financial
report must be sent to AASLD. In addition, the recipient must acknowledge support from AASLD in
all publications resulting from research performed during the tenure of this award.
SELECTION CRITERIA
Criteria used to judge proposals will include comments from the Summary Statement, the study
section priority score, and the quality of the research. Priority will be given to more junior applicants
and those whose topics fulfill the research mission of AASLD and the NIH Liver Action Plan.
Significant priority will be given to applicants whose institution demonstrates a commitment to
provide matching funds. Before the grant is paid, a final review of “Other Support” should be
submitted to ensure ongoing need for the bridge funds.
REVIEW PROCESS
All applications will be reviewed by the AASLD Awards Committee. Incomplete applications and
applications that fail to adhere strictly to the instructions (including submission deadline
and page limitations) will not be reviewed.
SUBMISSION PROCESS AND DEADLINE
The application packet, which is to include the award application, letters of support or commitment
and other documents as applicable, must be submitted as one PDF document to awards@aasld.org.
Note: Letters of support or commitment sent individually will not be considered. Hard copies are
not permitted.
The application deadline for this award is 5:00 pm Eastern time on September 2, 2008.
NOTIFICATION DATE/START DATE
Notification will be made in October with a funding start date of November 15.
American Association for the Study of Liver Diseases
1001 N. Fairfax Street, Suite 400
Alexandria VA 22314
PH: 703-299-9766
www.aasld.org
Hepatologist
Request for Proposals Frontotemporal Dementia Drug Discovery Program
Alzheimer’s Drug Discovery Foundation
All Regions
09/22/2008
$0
REQUEST FOR PROPOSALS
Frontotemporal Dementia Drug Discovery Program
The Alzheimer’s Drug Discovery Foundation (ADDF) and The Association for Frontotemporal Dementias (AFTD) seek to accelerate and support drug discovery for FTD and related dementias through this Request for Proposals (RFP.
Research investigating the pathologic mechanisms of neurodegeneration in frontotemporal dementia (FTD) and related disorders has advanced recently, creating new potential targets for drug discovery.
Examples of programs appropriate for this RFP include, but are not limited to:
• Identification and in vitro testing of potentially disease modifying lead compounds
• Development and testing of novel high throughput screening assays
• Medicinal chemistry on lead compounds
• Testing of lead compounds in a relevant animal model for preclinical proof of concept
• ADME, toxicology, pharmacokinetics, pharmacodynamics on lead compounds
• Development and testing of targeted gene delivery strategies
• Development of biomarkers to accelerate drug development and early diagnosis
PLEASE NOTE: THIS FUNDING WILL NOT SUPPORT APPLICATIONS FOR BASIC RESEARCH
MECHANISM(S) OF SUPPORT
ADDF/AFTD will provide individual grants for one year duration with the possibility of follow on funding. Applications may be submitted by non-profit academic institutions and for-profit biotechnology companies, both public and private, worldwide. Collaborative teams of neuroscientists and researchers in drug discovery disciplines such as medicinal chemistry and drug delivery are also encouraged to apply.
REVIEW PROCESS
The deadline date for applications is September 22nd, 2008. Applications will be confidentially reviewed by ADDF and an external Scientific Review Committee, including AFTD scientific advisors. Applications from biotechnology companies will also be reviewed by ADDF’s external Business Advisory Board. Award-winners will be publicly announced in April 2009.
APPLICATION PROCEDURE
All applications must be submitted electronically at www.AlzDiscovery.org.
Clinical Pharmacist, Medicinal Chemist, Neuroscientist, Scientist, Toxicologist
Macular Degeneration Research Program
American Health Assistance Foundation
All Regions
07/10/2008
$10,000

The Macular Degeneration Research Program (MDR) is a new program of AHAF. Since 1999, AHAF has awarded over $7.7 million to support basic research into the causes and potential treatments of this disease. MDR is currently supporting 25 biomedical researchers.

Standard Award (maximum of $50,000 per year for up to two years, renewable on a competitive basis)

For the 2009 competition, the Letters of Intent are due at AHAF by July 10, 2008. The Grant Application Information page has specific Letter of Intent instructions. If you are invited to submit an application, it must be received by October 20, 2008.

Macular Degeneration Research

MDR employs a two tiered review process in which proposals are first submitted by Letter of Intent. The Letters are individually ranked by 3-5 reviewers. These preliminary grades are not accompanied by formal written critiques of the proposal, and are used solely as a triage process to identify only the most competitive proposals.

In consultation with the Chair of the MDR Scientific Review Committee the AHAF Research Grants Staff invites the most enthusiastically reviewed Letters of Intent to submit a full application, which are reviewed as noted above.

The cut-off line is based on number of received proposals and fluctuates each year.

American Health Assistance Foundation
22512 Gateway Center Drive
Clarksburg, Maryland 20871

Phone:
1-800-437-2423 or (301) 948-3244
Fax:
(301) 258-9454

Research Grants
Guy Eakin, Ph.D., Director of Research Grants: geakin@ahaf.org

Ophthalmologist
Request for Skin Cancer Career Development Awards: SPORE—Skin Cancer
Brigham and Women’s Hospital
All Regions
07/15/2008
$0
Request for Skin Cancer Career Development Awards: SPORE—Skin Cancer
The SPORE in Skin Cancer is seeking one (1) career development project for funding in the sixth year of the grant. SPORE’s are large NCI interdisciplinary program grants which focus on translational research in a specific human disease field (e.g. skin cancer, including melanoma, squamous cell carcinoma, cutaneous lymphoma, etc.). They emphasize the rapid movement of discoveries made in the lab to the clinical setting, and promote laboratory investigations seeking to explain clinical observations.

Specifically, independent investigators with an interest in studying biologic, epidemiologic, preclinical or therapeutic modalities, which are directly or potentially applicable to human skin cancer, are encouraged to apply. All career development projects must have a goal to be translatable in the study of human skin cancer. Awardees will be expected to participate in the activities of the SPORE, including attending research retreats and presenting research accomplishments. The goal of the Career Development Award Program is to attract basic, translational and clinical investigators into skin cancer research, to enrich their foundation of knowledge about human skin cancer, mentor them in their chosen career pathways, and integrate the recipients into the translational mission of the SPORE.

Candidates may be either clinicians or basic scientists with an MD or PhD degree, who are interested in translational research and in pursuing a career as an independent investigator in cutaneous oncology research. We will consider senior level postdoctoral fellows who are moving into faculty status and instructor level junior faculty within three years of completing their training who are interested in pursuing hypothesis driven research. The typical applicant is a junior faculty member with a strong program of research, a secure position in a mentoring environment, and the need for funding as a bridge to independence. Consideration is also given to established investigators interested in shifting their research focus to skin cancer.

Examples of projects, which might be suitable for developmental projects, include:
• New diagnostic tests/techniques for identifying or characterizing skin cancer
• Work with animal models of skin cancer
• Study potential genes and/or proteins important in skin carcinogenesis
• Therapeutic trials

Applications should be no more than 5 pages. Please follow the format outlined below.

• Detailed Budget (not counted in the 5 page limit)
• Introduction and Specific Aim
• Preliminary data
• Experimental design
• References (not counted in 5-page limit)

Application Timelines:

Applications are due July 15, 2008
Funding will begin September 1, 2008

Applications should be sent to:

Brigham and Women’s Hospital
Michelle Gagne
Department of Dermatology
801 Massachusetts Ave. Suite 718
Boston, MA 02118

For additional information please contact Michelle Gagne at 617-582-0080 or mgagne1@partners.org
Physician Researcher, Junior Faculty, Junior Investigator, Junior Researcher, Junior Scientist, Oncologist
Travel Stipends For Under-Represented Researchers
Conference on Innovations in Trauma Research Methods
All Regions
07/15/2008
$0

Conference on Innovations in Trauma Research Methods
November 16-17, 2008
Hotel Orrington
Chicago's North Shore

CITRM 2008

TRAVEL STIPENDS FOR UNDER-REPRESENTED RESEARCHERS
DEADLINE: JULY 15, 2008

Thank you for your interest in CITRM travel stipends. Travel stipends are provided on a competitive basis to members of under-represented groups, with application materials submitted to the CITRM Travel Stipend Selection Committee. "Under-represented" is here defined as members of a North American racial or ethnic minority group (including African American, Hispanic American, Asian American, Native American, or Pacific Islander); a member of a legally-defined physically challenged group; or a citizen or permanent resident of those nations with economies defined by the World Bank as low income, lower middle income, or upper middle income, on the basis of gross national income (for a complete list of World Bank-categorized nations, see website link:

http://web.worldbank.org/WBSITE/EXTERNAL/DATASTATISTICS/0,,contentMDK:20421402~menuPK:64133156~pagePK:64133150~piPK:64133175~theSitePK:239419,00.html#lincome.).

Stipends are available for both novice researchers and more experienced scientists. "Novice Researchers" are defined as those who completed training less than 5 years prior to application time. In turn, "Experienced Researchers" are defined as individuals who completed training 5 or more years prior to application. Stipends will include conference fee waiver and funding toward airfare and lodging at the CITRM conference hotel.

For more information, contact Lauren McSweeney at: Lauren.McSweeney@va.gov.

African-American, Asian-American, Latino/Hispanic, Minority Member, Minority Scientist, Native American, Established Investigator, Novice Researcher, Critical Care Physician
Parker B. Francis Fellowship in Pulmonary Research
Francis Family Foundation
All Regions
10/17/2008
$156,000

The Parker B. Francis Fellowship in Pulmonary Research is intended to support the development of outstanding investigators who plan careers in pulmonary research. We seek to help them as they make the transition to independent, self-supporting, faculty members.

Parker B. Francis Fellowship grants are awarded to institutions for the purpose of providing stipends, fringe benefits, and modest travel expenses in support of qualified post-doctoral fellows or newly appointed assistant professors. Award recipients will thereby be enabled to devote the major part of their professional effort to research related to pulmonary disease and lung biology.

Grants are made for three years of support. It is permissible to maintain support for the awardee as he or she moves from fellowship to faculty status. Awards are made to institutions on behalf of the fellows and can be transferred to other institutions only under special circumstances with prior approval from the Director of the Fellowship Program.

Fellows supported by a Parker B. Francis Fellowship must be assured of having at least 75 percent of their time available for research. This means that a total of no more than three months per year may be spent in clinical or other non-research activities.

GENERAL INFORMATION

APPLICANTS
The ideal candidate is one with evidence of strong aptitude in research and who is in transition from post-doctoral trainee to independent investigator. It is essential that there be evidence of accomplishment and proficiency in research. Few applicants who are just beginning research training and have only one or two research publications are funded. Candidates with greater than seven years since the doctoral degree should include reasons for continued training. Candidates may hold any relevant doctoral degree (e.g., M.D., Ph.D., Sc.D., D.V.M., Dr. P.H.). Fellowships are restricted to US, Canadian and Mexican citizens or permanent residents. However, foreign nationals who document their initial steps toward permanent residence in the US, Canada or Mexico will also be considered. Documentation should include a description of steps already taken toward application for long-term residency or citizenship.

MENTORS
Mentorship of the fellow by an established investigator is required. Any established faculty scientist at a university or a not-for-profit research institution may mentor a candidate for fellowship. Mentors at government or corporate laboratories are not eligible. The mentor should be in a position to guarantee that 75 percent of a fellow's time is available for research. The mentor should be committed to fostering the candidate's career advancement and should be the primary scientific advisor. Secondary scientific mentors at the same or a different institution are encouraged but not required. Their roles should be described in the body of the application. Many fellows spend some portion of their fellowship years working with a secondary mentor at another institution.

INSTITUTIONS
There are no restrictions regarding discipline or department. Clinical or basic science departments are suitable; however, it is expected that the proposed research will focus on lung biology or lung disease. Awards are limited to institutions located in the US, Canada and Mexico. Each department may submit only one application annually and is limited to a maximum of two active fellowships at any one time.

NOTES ABOUT OTHER GRANT SUPPORT

Having an NIH K series or similar award at the time of application makes one ineligible for a PBF Fellowship. However, once awarded, a PBF Fellow may accept such a grant, as long as the basic requirements of the PBF Fellowship are met (75 percent of time available for research and PBF funds used only for salary and travel). Most importantly, the area of lung research pursued should remain the same.
Previous individual or institutional NIH or MRC training grants do not make one ineligible, although they must be relinquished if a PBF Fellowship is awarded.
Individuals are ineligible for a PBF Fellowship if they are the principal investigator on an NIH RO1 or similar research grant when applying for a PBF Fellowship. But Fellows in their second or third year may have their own NIH RO1 or similar grant. In fact, obtaining research grants is an appropriate goal for PBF Fellows. Since fellowship funds are restricted to the Fellow's salary and travel, in some cases it may not be possible to utilize the full level of PBF Fellowship support.
Awards will not be given if either the fellow or mentor currently holds funding from the tobacco industry, even if the tobacco monies will not be used to support the PBF sponsored research.
APPROPRIATE TOPICS
A broad array of approaches to lung biology and respiratory medicine, ranging from cell and molecular studies, to those involving epidemiologic and clinical aspects of human subjects are appropriate. We also encourage applications from pulmonary medicine specialists interested in pursuing research in bioethical aspects of pulmonary medicine or critical care. Potential topics include, but are not limited to, the ethics of clinical trials in critical care, end-of-life decisions and resource allocation. The context of all these topics should be pulmonary biology and lung disease. Applicants must meet all the eligibility standards. Mentors and/or applicants considering whether a particular area is appropriate are encouraged to discuss potential projects with the Director of the PBF Fellowship Program in Seattle, Washington (trmartin@u.washington.edu).

MAILING ADDRESS

Thomas R. Martin, M.D.
Director
Parker B. Francis Fellowship Program
Pulmonary Research Laboratories
VA Puget Sound Health Care System
1660 S. Columbian Way, 151L
Seattle, WA 98108

DEADLINE

Applications must be received no later than Friday, October 17, 2008.

Junior Faculty, Junior Investigator, Junior Researcher, Junior Scientist, Pulmonologist , Young Investigator, Young Scientist, Cell Biologist, Molecular Biologist , Epidemiologogist

23456789101126next